Repozytorium UR

Clinical aspects of protein glycation

DSpace Repository

Show simple item record

dc.contributor.author Galiniak, Sabina
dc.contributor.author Krawczyk-Marć, Izabela
dc.contributor.author Sęk-Mastej, Anna
dc.contributor.author Leksa, Natalia
dc.contributor.author Biesiadecki, Marek
dc.contributor.author Orkisz, Stanisław
dc.date.accessioned 2018-04-04T12:53:29Z
dc.date.available 2018-04-04T12:53:29Z
dc.date.issued 2017
dc.identifier.citation European Journal of Clinical and Experimental Medicine T. 15, z. 3 (2017), s. 263–267 pl_PL.UTF-8
dc.identifier.issn 2544-2406
dc.identifier.uri http://repozytorium.ur.edu.pl/handle/item/3503
dc.description.abstract Introduction. Glycation is a post-translational modification of proteins that depends on the non-enzymatic linkage of a ketone or aldehyde group of sugar with a free amino group of protein. Pathological effects of this process are observed in many disease states under conditions of hyperglycemia, in diabetic complications, and neurodegenerative diseases such as multiple sclerosis. Aim. In this paper we present the characteristics of the glycation process, its consequences, as well as a review of current knowledge about the role of glycation in multiple sclerosis. Material and methods. The databases EBSCO, PubMed, ScienceDirect and SpringerLink were used to search the literature. Analysis of the literature. Intermediate glycation products form a number of derivatives that contribute to oxidative stress and structural changes in the proteins, including induction of aggregation or reduction of affinity for drug proteins. Glucose products may contribute to neurodegenerative changes in patients with multiple sclerosis. Determination of protein glycation products can be successfully used to evaluate the course of multiple sclerosis as a diagnostic marker. pl_PL.UTF-8
dc.language.iso eng pl_PL.UTF-8
dc.publisher Wydawnictwo Uniwersytetu Rzeszowskiego pl_PL.UTF-8
dc.rights Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/ *
dc.subject AGEs pl_PL.UTF-8
dc.subject glycation pl_PL.UTF-8
dc.subject advanced glycation end products pl_PL.UTF-8
dc.subject multiple sclerosis pl_PL.UTF-8
dc.title Clinical aspects of protein glycation pl_PL.UTF-8
dc.type article pl_PL.UTF-8
dc.identifier.doi 10.15584/ejcem.2017.3.10
dc.identifier.eissn 2544-1361


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe

Search DSpace


Browse

My Account

Statistics

Informacje